Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users
This study has been completed.
Study NCT00194480   Information provided by National Institute on Drug Abuse (NIDA)
First Received: September 12, 2005   Last Updated: October 24, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Substance-Related Disorders
Hepatitis
Additional conditions recognized in this trial
Hepatitis C
Virus Diseases
More general conditions related to this trial
Digestive System Diseases
Disorders of Environmental Origin
Flaviviridae Infections
Hepatitis, Viral, Human
Liver Diseases
Mental Disorders
RNA Virus Infections
Interventions listed in this trial
Pegylated Interferon
Additional drug interventions recognized in this trial
Interferons
More general drug interventions related to this trial
Anti-Infective Agents
Antineoplastic Agents
Antiviral Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)
University of Washington


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services